How Can You Manage the Complexity of Early Phase Clinical Development?

Xtalks spoke with Dr. Oren Cohen, Chief Medical Officer (CMO) and President of Clinical Pharmacology at Fortrea, to learn about the complexities of early phase clinical development and innovative approaches to managing them.

Dr. Cohen has served as CMO of the company since Fortrea’s launch as an independent company in July 2023 following its spinoff from Labcorp. He brings expertise to optimizing early clinical development through excellence in study design and execution.

With costs soaring and competition intensifying, learn how strategic innovations and robust risk management are reshaping the approach to developing new therapies.

#XtalksSpotlight #Clinical Trials #Clinical Research #Clinical Development #EarlyPhaseTrials #EarlyPhaseClinicalTrials #EarlyClinicalDevelopment #EarlyPhase #EarlyPhaseDrugDevelopment #Pharmacology #ClinicalPharmacology